Key clinical point: Testosterone gel boosts LV mass.
Major finding: Left ventricular mass rose by 3.5% over the course of 1 year of testosterone gel therapy for low testosterone in older men.
Study details: The Testosterone Cardiovascular Trial, a randomized, multicenter, double-blind, placebo-controlled clinical study of 123 older men with andropause.
Disclosures: The presenter reported having no financial conflicts regarding the study, sponsored by the National Institutes of Health.
Hutchins E. AHA 2019, session FS.AOS.04.